1 May 2023 false Taxfiler 2024.6 08477790business:PrivateLimitedCompanyLtd2023-05-012024-04-30 084777902023-04-30 084777902023-05-012024-04-30 08477790business:AuditExemptWithAccountantsReport2023-05-012024-04-30 08477790business:FilletedAccounts2023-05-012024-04-30 084777902024-04-30 08477790business:Director12023-05-012024-04-30 08477790business:RegisteredOffice2023-05-012024-04-30 084777902023-04-30 08477790core:WithinOneYear2024-04-30 08477790core:WithinOneYear2023-04-30 08477790core:AfterOneYear2024-04-30 08477790core:AfterOneYear2023-04-30 08477790core:ShareCapitalcore:PreviouslyStatedAmount2024-04-30 08477790core:ShareCapitalcore:PreviouslyStatedAmount2023-04-30 08477790core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-04-30 08477790core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-04-30 08477790core:PreviouslyStatedAmount2024-04-30 08477790core:PreviouslyStatedAmount2023-04-30 08477790business:SmallEntities2023-05-012024-04-30 08477790countries:EnglandWales2023-05-012024-04-30 08477790core:PlantMachinery2023-05-012024-04-30 08477790core:MotorVehicles2023-05-012024-04-30 08477790core:FurnitureFittings2023-05-012024-04-30 08477790core:ComputerEquipment2023-05-012024-04-30 08477790core:Goodwill2023-04-30 08477790core:Goodwill2023-05-012024-04-30 08477790core:Goodwill2024-04-30 08477790core:PlantMachinery2023-04-30 08477790core:MotorVehicles2023-04-30 08477790core:FurnitureFittings2023-04-30 08477790core:ComputerEquipment2023-04-30 08477790core:PlantMachinery2024-04-30 08477790core:MotorVehicles2024-04-30 08477790core:FurnitureFittings2024-04-30 08477790core:ComputerEquipment2024-04-30 08477790business:OrdinaryShareClass12023-05-012024-04-30 08477790business:OrdinaryShareClass12022-05-012023-04-30 084777902022-05-012023-04-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 08477790 (England and Wales)
Jela Pharm Limited Filleted accounts for the year ended 30 April 2024
Jela Pharm Limited Filleted accounts Contents
Page
- 2 -
Jela Pharm Limited Company Information for the year ended 30 April 2024
Director
Romin Tayub
Company Number
08477790 (England and Wales)
Registered Office
Somerby Pharmacy 11a Leicester Road Oadby Leicester Leicestershire LE2 5BD England
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Jela Pharm Limited Statement of financial position as at 30 April 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
750,631 
- 
Tangible assets
279,813 
110,749 
1,030,444 
110,749 
Current assets
Inventories
27,555 
- 
Debtors
538,148 
264,636 
Cash at bank and in hand
213,005 
109,936 
778,708 
374,572 
Creditors: amounts falling due within one year
(653,939)
(166,834)
Net current assets
124,769 
207,738 
Total assets less current liabilities
1,155,213 
318,487 
Creditors: amounts falling due after more than one year
(586,021)
(84,428)
Net assets
569,192 
234,059 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
569,191 
234,058 
Shareholders' funds
569,192 
234,059 
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 28 January 2025 and were signed on its behalf by
Romin Tayub Director Company Registration No. 08477790
- 4 -
Jela Pharm Limited Notes to the Accounts for the year ended 30 April 2024
1
Statutory information
Jela Pharm Limited is a private company, limited by shares, registered in England and Wales, registration number 08477790. The registered office is Somerby Pharmacy, 11a Leicester Road, Oadby, Leicester, Leicestershire, LE2 5BD, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
15% reducing balance
Motor vehicles
25% straight line
Fixtures & fittings
25% straight line
Computer equipment
25% straight line
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
- 5 -
Jela Pharm Limited Notes to the Accounts for the year ended 30 April 2024
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 May 2023
- 
Additions
750,631 
At 30 April 2024
750,631 
Amortisation
At 1 May 2023
- 
At 30 April 2024
- 
Net book value
At 30 April 2024
750,631 
5
Tangible fixed assets
Plant & machinery 
Motor vehicles 
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At cost 
At cost 
At 1 May 2023
3,500 
84,940 
66,653 
5,142 
160,235 
Additions
- 
11,500 
190,863 
10,399 
212,762 
At 30 April 2024
3,500 
96,440 
257,516 
15,541 
372,997 
Depreciation
At 1 May 2023
2,689 
15,127 
31,381 
289 
49,486 
Charge for the year
122 
23,780 
17,009 
2,787 
43,698 
At 30 April 2024
2,811 
38,907 
48,390 
3,076 
93,184 
Net book value
At 30 April 2024
689 
57,533 
209,126 
12,465 
279,813 
At 30 April 2023
811 
69,813 
35,272 
4,853 
110,749 
6
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
VAT
62,834 
36,258 
Trade debtors
13,136 
190,472 
Amounts due from group undertakings etc.
14,000 
22,500 
Accrued income and prepayments
429,053 
3,809 
Other debtors
- 
4,222 
519,023 
257,261 
Amounts falling due after more than one year
Accrued income and prepayments
19,125 
7,375 
- 6 -
Jela Pharm Limited Notes to the Accounts for the year ended 30 April 2024
7
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Bank loans and overdrafts
69,215 
- 
Obligations under finance leases and hire purchase contracts
8,275 
- 
Trade creditors
363,068 
118,468 
Amounts owed to group undertakings and other participating interests
100,000 
- 
Taxes and social security
57,032 
22,062 
Other creditors
24,216 
17,807 
Loans from directors
29,461 
- 
Accruals
2,672 
8,497 
653,939 
166,834 
8
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Bank loans
586,021 
84,428 
9
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1 
1 
10
Average number of employees
During the year the average number of employees was 20 (2023: 7).
- 7 -